Cargando…
Efficacy of a Validated Yoga Protocol on Dyslipidemia in Diabetes Patients: NMB-2017 India Trial
Background: Dyslipidemia is considered a risk factor in Type 2 diabetes mellitus (T2DM) resulting in cardio-vascular complications. Yoga practices have shown promising results in alleviating Type 2 Diabetes pathology. Method: In this stratified trial on a Yoga based lifestyle program in cases with T...
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6963794/ https://www.ncbi.nlm.nih.gov/pubmed/31614579 http://dx.doi.org/10.3390/medicines6040100 |
_version_ | 1783488363427266560 |
---|---|
author | Nagarathna, Raghuram Tyagi, Rahul Kaur, Gurkeerat Vendan, Vetri Acharya, Ishwara N. Anand, Akshay Singh, Amit Nagendra, Hongasandra R. |
author_facet | Nagarathna, Raghuram Tyagi, Rahul Kaur, Gurkeerat Vendan, Vetri Acharya, Ishwara N. Anand, Akshay Singh, Amit Nagendra, Hongasandra R. |
author_sort | Nagarathna, Raghuram |
collection | PubMed |
description | Background: Dyslipidemia is considered a risk factor in Type 2 diabetes mellitus (T2DM) resulting in cardio-vascular complications. Yoga practices have shown promising results in alleviating Type 2 Diabetes pathology. Method: In this stratified trial on a Yoga based lifestyle program in cases with Type 2 diabetes, in the rural and urban population from all zones of India, a total of 17,012 adults (>20 years) of both genders were screened for lipid profile and sugar levels. Those who satisfied the selection criteria were taught the Diabetes Yoga Protocol (DYP) for three months and the data were analyzed. Results: Among those with Diabetes, 29.1% had elevated total cholesterol (TC > 200 mg/dL) levels that were higher in urban (69%) than rural (31%) Diabetes patients. There was a positive correlation (p = 0.048) between HbA1c and total cholesterol levels. DYP intervention helped in reducing TC from 232.34 ± 31.48 mg/dL to 189.38 ± 40.23 mg/dL with significant pre post difference (p < 0.001). Conversion rate from high TC (>200 mg/dL) to normal TC (<200 mg/dL) was observed in 60.3% of cases with Type 2 Diabetes Mellitus (T2DM); from high LDL (>130 mg/dL) to normal LDL (<130 mg/dL) in 73.7%; from high triglyceride (>200 mg/dL) to normal triglyceride level (<200 mg/dL) in 63%; from low HDL (<45 mg/dL) to normal HDL (>45 mg/dL) in 43.7% of T2DM patients after three months of DYP. Conclusions: A Yoga lifestyle program designed specifically to manage Diabetes helps in reducing the co-morbidity of dyslipidemia in cases of patients with T2DM. |
format | Online Article Text |
id | pubmed-6963794 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2019 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-69637942020-01-27 Efficacy of a Validated Yoga Protocol on Dyslipidemia in Diabetes Patients: NMB-2017 India Trial Nagarathna, Raghuram Tyagi, Rahul Kaur, Gurkeerat Vendan, Vetri Acharya, Ishwara N. Anand, Akshay Singh, Amit Nagendra, Hongasandra R. Medicines (Basel) Article Background: Dyslipidemia is considered a risk factor in Type 2 diabetes mellitus (T2DM) resulting in cardio-vascular complications. Yoga practices have shown promising results in alleviating Type 2 Diabetes pathology. Method: In this stratified trial on a Yoga based lifestyle program in cases with Type 2 diabetes, in the rural and urban population from all zones of India, a total of 17,012 adults (>20 years) of both genders were screened for lipid profile and sugar levels. Those who satisfied the selection criteria were taught the Diabetes Yoga Protocol (DYP) for three months and the data were analyzed. Results: Among those with Diabetes, 29.1% had elevated total cholesterol (TC > 200 mg/dL) levels that were higher in urban (69%) than rural (31%) Diabetes patients. There was a positive correlation (p = 0.048) between HbA1c and total cholesterol levels. DYP intervention helped in reducing TC from 232.34 ± 31.48 mg/dL to 189.38 ± 40.23 mg/dL with significant pre post difference (p < 0.001). Conversion rate from high TC (>200 mg/dL) to normal TC (<200 mg/dL) was observed in 60.3% of cases with Type 2 Diabetes Mellitus (T2DM); from high LDL (>130 mg/dL) to normal LDL (<130 mg/dL) in 73.7%; from high triglyceride (>200 mg/dL) to normal triglyceride level (<200 mg/dL) in 63%; from low HDL (<45 mg/dL) to normal HDL (>45 mg/dL) in 43.7% of T2DM patients after three months of DYP. Conclusions: A Yoga lifestyle program designed specifically to manage Diabetes helps in reducing the co-morbidity of dyslipidemia in cases of patients with T2DM. MDPI 2019-10-11 /pmc/articles/PMC6963794/ /pubmed/31614579 http://dx.doi.org/10.3390/medicines6040100 Text en © 2019 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Nagarathna, Raghuram Tyagi, Rahul Kaur, Gurkeerat Vendan, Vetri Acharya, Ishwara N. Anand, Akshay Singh, Amit Nagendra, Hongasandra R. Efficacy of a Validated Yoga Protocol on Dyslipidemia in Diabetes Patients: NMB-2017 India Trial |
title | Efficacy of a Validated Yoga Protocol on Dyslipidemia in Diabetes Patients: NMB-2017 India Trial |
title_full | Efficacy of a Validated Yoga Protocol on Dyslipidemia in Diabetes Patients: NMB-2017 India Trial |
title_fullStr | Efficacy of a Validated Yoga Protocol on Dyslipidemia in Diabetes Patients: NMB-2017 India Trial |
title_full_unstemmed | Efficacy of a Validated Yoga Protocol on Dyslipidemia in Diabetes Patients: NMB-2017 India Trial |
title_short | Efficacy of a Validated Yoga Protocol on Dyslipidemia in Diabetes Patients: NMB-2017 India Trial |
title_sort | efficacy of a validated yoga protocol on dyslipidemia in diabetes patients: nmb-2017 india trial |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6963794/ https://www.ncbi.nlm.nih.gov/pubmed/31614579 http://dx.doi.org/10.3390/medicines6040100 |
work_keys_str_mv | AT nagarathnaraghuram efficacyofavalidatedyogaprotocolondyslipidemiaindiabetespatientsnmb2017indiatrial AT tyagirahul efficacyofavalidatedyogaprotocolondyslipidemiaindiabetespatientsnmb2017indiatrial AT kaurgurkeerat efficacyofavalidatedyogaprotocolondyslipidemiaindiabetespatientsnmb2017indiatrial AT vendanvetri efficacyofavalidatedyogaprotocolondyslipidemiaindiabetespatientsnmb2017indiatrial AT acharyaishwaran efficacyofavalidatedyogaprotocolondyslipidemiaindiabetespatientsnmb2017indiatrial AT anandakshay efficacyofavalidatedyogaprotocolondyslipidemiaindiabetespatientsnmb2017indiatrial AT singhamit efficacyofavalidatedyogaprotocolondyslipidemiaindiabetespatientsnmb2017indiatrial AT nagendrahongasandrar efficacyofavalidatedyogaprotocolondyslipidemiaindiabetespatientsnmb2017indiatrial |